研究者
J-GLOBAL ID：201801000757343604
更新日: 2024年11月03日
野尻 俊輔
Nojiri Shunsuke
所属機関・部署：
職名：
教授
研究キーワード (4件)：
漢方
, 肝硬変
, 肝癌
, 肝臓
競争的資金等の研究課題 (5件)：
- 2020 - 2023 p68の肝癌細胞及び肝癌血管内皮細胞における機能解析
- 2019 - 2022 肝細胞と星細胞の相互作用がもたらすNASH病態ダイナミクス
- 2019 - 2022 肝炎等克服実用化研究事業(肝炎等克服緊急対策研究事業
- 2016 - 2019 肝線維化からみた肝発癌メカニズムの解明と新規治療法の開発
- 2012 - 2016 肝硬変への進展を阻止する新しい観点からの治療法の開発
論文 (22件)：
-
Daisuke Kato, Takanori Suzuki, Kentaro Matsuura, Kohei Okayama, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Katsumi Hayashi, Atsunori Kusakabe, Izumi Hasegawa, et al. Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study. Oncology. 2024. 1-9
-
Takanori Suzuki, Kentaro Matsuura, Naoto Imura, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Shogo Ito, Takao Togawa, Hiromi Kataoka. Adult-onset Type II Citrullinemia Developed under Dietary Restrictions during Imprisonment. Internal medicine (Tokyo, Japan). 2024. 63. 6. 833-837
-
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Daisuke Kato, Atsunori Kusakabe, Hiroki Koguchi, Izumi Hasegawa, et al. Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study. Oncology. 2024. 1-12
-
Yoshihito Nagura, Takanori Suzuki, Kentaro Matsuura, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Katsuya Nagaoka, Etsuko Iio, et al. Serum inducible protein 10 kDa/C-X-C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Hepatology research : the official journal of the Japan Society of Hepatology. 2024. 54. 1. 32-42
-
Takanori Suzuki, Kentaro Matsuura, Takehisa Watanabe, Takeshi Matsui, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, et al. Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance. Journal of medical virology. 2023. 95. 9. e29109
もっと見る
MISC (18件)：
-
Kentaro Matsuura, Etsuko Iio, Nobuhiro Aizawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hidenori Toyoda, Takashi Kumada, Kayoko Matsunami, Kei Fujiwara, Shunsuke Nojiri, et al. Circulating let-7 levels in serum and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C. HEPATOLOGY. 2017. 66. 238A-239A
-
Etsuko Iio, Noritomo Shimada, Kentaro Matsuura, Masanori Atsukawa, Koichi Takaguchi, Yuichiro Eguchi, Hideyuki Nomura, Noboru Hirashima, Akihito Tsubota, Atsunori Kusakabe, et al. Investigating the association of TLL1 variant with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free regimens. HEPATOLOGY. 2017. 66. 521A-521A
-
Kei Fujiwara, Kentaro Matsuura, Kayoko Matsunami, Etsuko Iio, Shunsuke Nojiri, Takashi Joh. Novel non-canonical genetic rearrangements termed "complex structural variations" in HBV genome. HEPATOLOGY. 2017. 66. 805A-805A
-
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus. HEPATOLOGY. 2017. 66. 476A-476A
-
Shunsuke Nojiri, Kei Fujiwara, Noboru Shinkai, Etsuko Iio, Takashi Joh. The Dead Box Protein P68 Can Supress The Carcinogenesis And A-Fetoprotein (AFP) Gene Expression via Binding The New Silencer Region Of AFP Gene. HEPATOLOGY. 2015. 62. 1160A-1161A
もっと見る
学位 (1件)：
受賞 (1件)：
- 2011/11 - アメリカ肝臓病学会 ベストポスター賞
所属学会 (5件)：
日本東洋医学会
, 日本肝臓学会
, 日本消化器内視鏡学会
, 日本消化器病学会
, 日本内科学会
